{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:52:42Z","timestamp":1774536762702,"version":"3.50.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T00:00:00Z","timestamp":1693353600000},"content-version":"am","delay-in-days":363,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.revmed.2022.04.036","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T22:39:30Z","timestamp":1658356770000},"page":"537-544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Les amyloses cardiaques\u00a0: \u00e9tat des lieux en 2022"],"prefix":"10.1016","volume":"43","author":[{"given":"S.","family":"Oghina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Delbarre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Poullot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Belhadj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Fanen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Damy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.revmed.2022.04.036_bib0305","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.revmed.2022.04.036_bib0310","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/CIRCULATIONAHA.104.489187","article-title":"Diagnosis and management of the cardiac amyloidoses","volume":"112","author":"Falk","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.revmed.2022.04.036_bib0315","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/13506129.2016.1257986","article-title":"Amyloid fibril proteins and amyloidosis: chemical identification and clinical classification International Society of Amyloidosis 2016\u00a0Nomenclature Guidelines","volume":"23","author":"Sipe","year":"2016","journal-title":"Amyloid"},{"issue":"23","key":"10.1016\/j.revmed.2022.04.036_bib0320","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1182\/blood.2020006913","article-title":"Management of AL amyloidosis in 2020","volume":"136","author":"Palladini","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2022.04.036_bib0325","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1750-1172-7-54","article-title":"AL Amyloidosis","volume":"7","author":"Desport","year":"2012","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"10.1016\/j.revmed.2022.04.036_bib0330","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1182\/bloodadvances.2018016402","article-title":"Epidemiology of AL amyloidosis: a real-world study using US claims data","volume":"2","author":"Quock","year":"2018","journal-title":"Blood Adv"},{"issue":"18","key":"10.1016\/j.revmed.2022.04.036_bib0335","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1200\/JCO.2004.03.029","article-title":"Serum cardiac troponins and N-Terminal Pro-Brain Natriuretic Peptide: a staging system for primary systemic amyloidosis","volume":"22","author":"Dispenzieri","year":"2004","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.revmed.2022.04.036_bib0340","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10741-014-9462-7","article-title":"Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs","volume":"20","author":"Casta\u00f1o","year":"2015","journal-title":"Heart Fail Rev"},{"issue":"7","key":"10.1016\/j.revmed.2022.04.036_bib0345","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1056\/NEJM199702133360703","article-title":"Variant-sequence transthyretin (Isoleucine 122) in late-onset cardiac amyloidosis in black Americans","volume":"336","author":"Jacobson","year":"1997","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.revmed.2022.04.036_bib0350","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/eurheartj\/ehv583","article-title":"Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness","volume":"37","author":"Damy","year":"2016","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.revmed.2022.04.036_bib0355","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/joim.12383","article-title":"Cardiac amyloidosis: where are we today?","volume":"278","author":"Patel","year":"2015","journal-title":"J Intern Med"},{"issue":"4","key":"10.1016\/j.revmed.2022.04.036_bib0360","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0002-9343(83)90443-6","article-title":"Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation","volume":"75","author":"Cornwell","year":"1983","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.revmed.2022.04.036_bib0365","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/07853890701842988","article-title":"Senile systemic amyloidosis affects 25\u00a0% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study","volume":"40","author":"Tanskanen","year":"2008","journal-title":"Ann Med"},{"key":"10.1016\/j.revmed.2022.04.036_bib0370","doi-asserted-by":"crossref","first-page":"749523","DOI":"10.3389\/fcvm.2021.749523","article-title":"Incidence and characterization of concealed cardiac amyloidosis among unselected elderly patients undergoing post-mortem examination","volume":"8","author":"Porcari","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.revmed.2022.04.036_bib0375","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijcard.2018.06.006","article-title":"Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population","volume":"270","author":"Mohamed-Salem","year":"2018","journal-title":"Int J Cardiol"},{"issue":"22","key":"10.1016\/j.revmed.2022.04.036_bib0380","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.revmed.2022.04.036_bib0385","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jchf.2020.12.005","article-title":"The impact of patients with cardiac amyloidosis in HFpEF trials","volume":"9","author":"Oghina","year":"2021","journal-title":"JACC Heart Fail"},{"issue":"38","key":"10.1016\/j.revmed.2022.04.036_bib0390","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Casta\u00f1o","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.revmed.2022.04.036_bib0395","article-title":"Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings","volume":"4","author":"Vergaro","year":"2019","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"10.1016\/j.revmed.2022.04.036_bib0400","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000506617","article-title":"When to suspect a diagnosis of amyloidosis","volume":"143","author":"Vaxman","year":"2020","journal-title":"Acta Haematol"},{"issue":"3","key":"10.1016\/j.revmed.2022.04.036_bib0405","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ejhf.1742","article-title":"Carpal tunnel syndrome in cardiac amyloidosis: implications for early diagnosis and prognostic role across the spectrum of aetiologies","volume":"22","author":"Milandri","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"17","key":"10.1016\/j.revmed.2022.04.036_bib0410","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.jacc.2018.07.092","article-title":"Tenosynovial and cardiac amyloidosis in patients undergoing carpal tunnel release","volume":"72","author":"Sperry","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.revmed.2022.04.036_bib0415","first-page":"1324","article-title":"Carpal tunnel syndrome and spinal canal stenosis: harbingers of transthyretin amyloid cardiomyopathy?","volume":"108","author":"Aus dem Siepen","year":"2019","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"key":"10.1016\/j.revmed.2022.04.036_bib0420","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.wneu.2020.06.228","article-title":"Wild-type transthyretin amyloidosis occurring in the ligamentum flavum of the cervicothoracic spine","volume":"142","author":"George","year":"2020","journal-title":"World Neurosurg"},{"issue":"10","key":"10.1016\/j.revmed.2022.04.036_bib0425","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/jama.2017.9236","article-title":"Association between ruptured distal biceps tendon and wild-type transthyretin cardiac amyloidosis","volume":"318","author":"Geller","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.revmed.2022.04.036_bib0430","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1054\/jhsb.2001.0571","article-title":"Localized amyloid deposition in trigger finger","volume":"26","author":"Cordiner-Lawrie","year":"2001","journal-title":"J Hand Surg Edinb Scotl"},{"issue":"4","key":"10.1016\/j.revmed.2022.04.036_bib0435","first-page":"226","article-title":"Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: can we identify affected patients earlier?","volume":"24","author":"Rubin","year":"2017","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"issue":"4","key":"10.1016\/j.revmed.2022.04.036_bib0440","first-page":"234","article-title":"Association between hearing loss and hereditary ATTR amyloidosis","volume":"26","author":"Bartier","year":"2019","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"issue":"1","key":"10.1016\/j.revmed.2022.04.036_bib0445","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0002-9149(82)90270-3","article-title":"Amyloid cardiomyopathy: characterization by a distinctive voltage\/mass relation","volume":"49","author":"Carroll","year":"1982","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.revmed.2022.04.036_bib0450","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.amjcard.2014.07.026","article-title":"Prevalence and prognostic significance of low QRS voltage among the three main types of cardiac amyloidosis","volume":"114","author":"Cyrille","year":"2014","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.revmed.2022.04.036_bib0455","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.ijcard.2012.05.097","article-title":"Prognostic value of fragmented QRS in cardiac AL amyloidosis","volume":"167","author":"Perlini","year":"2013","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.revmed.2022.04.036_bib0460","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCIMAGING.113.001396","article-title":"How to image cardiac amyloidosis","volume":"7","author":"Falk","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.revmed.2022.04.036_bib0465","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10741-014-9466-3","article-title":"Echocardiography in cardiac amyloidosis","volume":"20","author":"Falk","year":"2015","journal-title":"Heart Fail Rev"},{"issue":"19","key":"10.1016\/j.revmed.2022.04.036_bib0470","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.revmed.2022.04.036_bib0475","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10741-014-9470-7","article-title":"Cardiovascular magnetic resonance for amyloidosis","volume":"20","author":"Fontana","year":"2015","journal-title":"Heart Fail Rev"},{"issue":"4","key":"10.1016\/j.revmed.2022.04.036_bib0480","first-page":"246","article-title":"Noninvasive detection of cardiac involvement in patients with hereditary transthyretin associated amyloidosis using cardiac magnetic resonance imaging: a prospective study","volume":"21","author":"Deux","year":"2014","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"issue":"2","key":"10.1016\/j.revmed.2022.04.036_bib0485","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2013.10.008","article-title":"Native T1\u00a0mapping in transthyretin amyloidosis","volume":"7","author":"Fontana","year":"2014","journal-title":"JACC Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.revmed.2022.04.036_bib0490","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1148\/radiol.2021204192","article-title":"Diagnostic value of extracellular volume quantification and myocardial perfusion analysis at CT in cardiac amyloidosis","volume":"300","author":"Deux","year":"2021","journal-title":"Radiology"},{"issue":"48","key":"10.1016\/j.revmed.2022.04.036_bib0495","first-page":"49","article-title":"Definition of organ involvement and response to treatment in AL amyloidosis: an updated consensus opinion","volume":"17","author":"Gertz","year":"2010","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"issue":"30","key":"10.1016\/j.revmed.2022.04.036_bib0500","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","article-title":"A new staging system for cardiac transthyretin amyloidosis","volume":"39","author":"Gillmore","year":"2017","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.revmed.2022.04.036_bib0505","first-page":"212","article-title":"Role of natriuretic peptide to predict cardiac abnormalities in patients with hereditary transthyretin amyloidosis","volume":"20","author":"Damy","year":"2013","journal-title":"Amyloid Int J Exp Clin Investig Off J Int Soc Amyloidosis"},{"issue":"10","key":"10.1016\/j.revmed.2022.04.036_bib0510","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system","volume":"68","author":"Grogan","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.revmed.2022.04.036_bib0515","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosisCLINICAL PERSPECTIVE","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.revmed.2022.04.036_bib0520","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jcmg.2016.05.007","article-title":"Early phase 99Tc-HMDP scintigraphy for the diagnosis and typing of cardiac amyloidosis","volume":"10","author":"Galat","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"10","key":"10.1016\/j.revmed.2022.04.036_bib0525","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1007\/s00259-020-04753-7","article-title":"Extracardiac soft tissue uptake, evidenced on early 99mTc-HMDP SPECT\/CT, helps typing cardiac amyloidosis and demonstrates high prognostic value","volume":"47","author":"Malka","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.revmed.2022.04.036_bib0530","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/jeab095","article-title":"99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis","author":"Quarta","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"8","key":"10.1016\/j.revmed.2022.04.036_bib0535","doi-asserted-by":"crossref","first-page":"e04652","DOI":"10.1002\/ccr3.4652","article-title":"Scintigraphy false-positive results for cardiac amyloidosis in a patient with Danon disease","volume":"9","author":"Antukh","year":"2021","journal-title":"Clin Case Rep"},{"issue":"4","key":"10.1016\/j.revmed.2022.04.036_bib0540","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1002\/ehf2.13339","article-title":"False-positive bone scintigraphy denoting transthyretin amyloid in elderly hypertrophic cardiomyopathy","volume":"8","author":"Chimenti","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"10","key":"10.1016\/j.revmed.2022.04.036_bib0545","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.lpm.2016.07.001","article-title":"Les amyloses cardiaques: les reconna\u00eetre et les prendre en charge","volume":"45","author":"Bodez","year":"2016","journal-title":"Presse M\u00e9dicale"},{"issue":"16","key":"10.1016\/j.revmed.2022.04.036_bib0550","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC working group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.revmed.2022.04.036_bib0555","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10072-016-2760-1","article-title":"Minor salivary gland biopsy for the diagnosis of familial amyloid polyneuropathy","volume":"38","author":"Eduardo","year":"2017","journal-title":"Neurol Sci"},{"issue":"1","key":"10.1016\/j.revmed.2022.04.036_bib0560","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.annpat.2020.11.010","article-title":"[Cardiac amyloidosis]","volume":"41","author":"Poullot","year":"2021","journal-title":"Ann Pathol"},{"issue":"9727","key":"10.1016\/j.revmed.2022.04.036_bib0565","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(10)60482-5","article-title":"Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study","volume":"375","author":"Dispenzieri","year":"2010","journal-title":"Lancet Lond Engl"},{"issue":"6","key":"10.1016\/j.revmed.2022.04.036_bib0570","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/01.CIR.63.6.1285","article-title":"Digoxin sensitivity in amyloid cardiomyopathy","volume":"63","author":"Rubinow","year":"1981","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.revmed.2022.04.036_bib0575","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/13506129.2018.1449744","article-title":"Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?","volume":"25","author":"Muchtar","year":"2018","journal-title":"Amyloid"},{"issue":"2","key":"10.1016\/j.revmed.2022.04.036_bib0580","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.mayocp.2020.06.061","article-title":"Coagulation abnormalities in light chain amyloidosis","volume":"96","author":"Abdallah","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.revmed.2022.04.036_bib0585","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1182\/blood-2015-01-620302","article-title":"A European collaborative study of cyclophosphamide, bortezomib, and dexamethasone in upfront treatment of systemic AL amyloidosis","volume":"126","author":"Palladini","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2022.04.036_bib0590","first-page":"183","article-title":"Sequential cyclophosphamide-bortezomib-dexamethasone unmasks the harmful cardiac effect of dexamethasone in primary light-chain cardiac amyloidosis","volume":"76","author":"Le Bras","year":"2017","journal-title":"Eur J Cancer Oxf Engl 1990"},{"issue":"9","key":"10.1016\/j.revmed.2022.04.036_bib0595","doi-asserted-by":"crossref","first-page":"e0257189","DOI":"10.1371\/journal.pone.0257189","article-title":"Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement","volume":"16","author":"B\u00e9zard","year":"2021","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.revmed.2022.04.036_bib0300","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1200\/JCO.2011.38.5724","article-title":"Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements","volume":"30","author":"Kumar","year":"2012","journal-title":"J Clin Oncol"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S024886632200460X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S024886632200460X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:45:44Z","timestamp":1759337144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S024886632200460X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S024886632200460X"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2022.04.036","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les amyloses cardiaques\u00a0: \u00e9tat des lieux en 2022","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2022.04.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}